Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments

Chronic inflammation is considered a pressing health issue that needs resolving. Inflammatory disease such as inflammatory bowel disease requires a long-term medical regimen to prevent disease progression. Conventionally, lactoferrin is used to treat mild gastrointestinal tract and skin inflammation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu Pan, Zhao Liu, Yijie Wang, Linshen Zhang, Niying Chua, Lei Dai, Jun Chen, Chun Loong Ho
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/ab4ac9c866cc459ead9bf00b13aabf85
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ab4ac9c866cc459ead9bf00b13aabf85
record_format dspace
spelling oai:doaj.org-article:ab4ac9c866cc459ead9bf00b13aabf852021-12-01T19:10:50ZEvaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments2296-418510.3389/fbioe.2021.779018https://doaj.org/article/ab4ac9c866cc459ead9bf00b13aabf852021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fbioe.2021.779018/fullhttps://doaj.org/toc/2296-4185Chronic inflammation is considered a pressing health issue that needs resolving. Inflammatory disease such as inflammatory bowel disease requires a long-term medical regimen to prevent disease progression. Conventionally, lactoferrin is used to treat mild gastrointestinal tract and skin inflammation. Protease-digested lactoferrin fragments often exhibit improved therapeutic properties compared to full-length lactoferrin (flHLF). However, there are no studies on the use of protease-digested lactoferrin fragments to treat inflammation. Herein, we assess the anti-inflammatory properties of engineered recombinant lactoferrin fragments (rtHLF4, rteHLF1, and rpHLF2) on non-malignant colonic fibroblast cells and colorectal cancer cells. We found that rtHLF4 is 10 times more effective to prevent inflammation compared to flHLF. These results were investigated by looking into the reactive oxygen species (ROS) production, angiogenesis activity, and cellular proliferation of the treated cells. We have demonstrated in this study the anti-inflammatory properties of the flHLF and the various lactoferrin fragments. These results complement the anti-cancer properties of these proteins that were demonstrated in an earlier study.Yu PanZhao LiuYijie WangLinshen ZhangNiying ChuaLei DaiJun ChenChun Loong HoFrontiers Media S.A.articlelactoferrinanti-infammatoryprotease-digestednon-malignant colonic fibroblasts cellstNF-alphaBiotechnologyTP248.13-248.65ENFrontiers in Bioengineering and Biotechnology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic lactoferrin
anti-infammatory
protease-digested
non-malignant colonic fibroblasts cells
tNF-alpha
Biotechnology
TP248.13-248.65
spellingShingle lactoferrin
anti-infammatory
protease-digested
non-malignant colonic fibroblasts cells
tNF-alpha
Biotechnology
TP248.13-248.65
Yu Pan
Zhao Liu
Yijie Wang
Linshen Zhang
Niying Chua
Lei Dai
Jun Chen
Chun Loong Ho
Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments
description Chronic inflammation is considered a pressing health issue that needs resolving. Inflammatory disease such as inflammatory bowel disease requires a long-term medical regimen to prevent disease progression. Conventionally, lactoferrin is used to treat mild gastrointestinal tract and skin inflammation. Protease-digested lactoferrin fragments often exhibit improved therapeutic properties compared to full-length lactoferrin (flHLF). However, there are no studies on the use of protease-digested lactoferrin fragments to treat inflammation. Herein, we assess the anti-inflammatory properties of engineered recombinant lactoferrin fragments (rtHLF4, rteHLF1, and rpHLF2) on non-malignant colonic fibroblast cells and colorectal cancer cells. We found that rtHLF4 is 10 times more effective to prevent inflammation compared to flHLF. These results were investigated by looking into the reactive oxygen species (ROS) production, angiogenesis activity, and cellular proliferation of the treated cells. We have demonstrated in this study the anti-inflammatory properties of the flHLF and the various lactoferrin fragments. These results complement the anti-cancer properties of these proteins that were demonstrated in an earlier study.
format article
author Yu Pan
Zhao Liu
Yijie Wang
Linshen Zhang
Niying Chua
Lei Dai
Jun Chen
Chun Loong Ho
author_facet Yu Pan
Zhao Liu
Yijie Wang
Linshen Zhang
Niying Chua
Lei Dai
Jun Chen
Chun Loong Ho
author_sort Yu Pan
title Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments
title_short Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments
title_full Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments
title_fullStr Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments
title_full_unstemmed Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments
title_sort evaluation of the anti-inflammatory and anti-oxidative effects of therapeutic human lactoferrin fragments
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/ab4ac9c866cc459ead9bf00b13aabf85
work_keys_str_mv AT yupan evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments
AT zhaoliu evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments
AT yijiewang evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments
AT linshenzhang evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments
AT niyingchua evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments
AT leidai evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments
AT junchen evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments
AT chunloongho evaluationoftheantiinflammatoryandantioxidativeeffectsoftherapeutichumanlactoferrinfragments
_version_ 1718404648180645888